Ironwood Pharmaceuticals Inc (IRWD) — Cash Flow Reinvestment Rate
Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $5.12 Million. Explore Ironwood Pharmaceuticals Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ironwood Pharmaceuticals Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Ironwood Pharmaceuticals Inc across 7 annual periods. Also explore balance sheet size of Ironwood Pharmaceuticals Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Ironwood Pharmaceuticals Inc (2019–2025)
Year-by-year capital reinvestment analysis for Ironwood Pharmaceuticals Inc. For live market cap and broader valuation context, see Ironwood Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $34.00K | $127.04 Million | $34.00K | ▼ -90.2% |
| 2024 | 0.00x | $284.00K | $103.55 Million | $142.00K | ▼ -100.0% |
| 2023 | 5.57x | $1.02 Billion | $183.43 Million | $273.00K | ▲ +560887.6% |
| 2022 | 0.00x | $272.00K | $273.76 Million | $136.00K | ▼ -50.9% |
| 2021 | 0.00x | $530.00K | $261.89 Million | $265.00K | ▼ -90.7% |
| 2020 | 0.02x | $3.68 Million | $168.84 Million | $1.84 Million | ▼ -98.7% |
| 2019 | 1.71x | $18.33 Million | $10.72 Million | $7.19 Million | — |